Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Genealogy may affect clinical differences in systemic lupus erythmatosus patients

June 18, 2010 12:35 am | by EurekAlert | News | Comments

(European League Against Rheumatism) The effects of systemic lupus erythematosus (SLE) may differ based on the individual patient's genealogical heritage, according to results of a new study presented today at EULAR 2010, the Annual Congress of the European League Against...

TOPICS:

Expression of certain transporter proteins may predict resistance to drug therapy

June 18, 2010 12:35 am | by EurekAlert | News | Comments

(European League Against Rheumatism) The expression of a transporter protein called the breast cancer resistance protein in rheumatoid arthritis patients may indicate higher disease activity and could be a barrier to the effectiveness of disease-modifying antirheumatic drugs,...

TOPICS:

TGen partner, PBS-Bio, makes first breakthrough drug analysis

June 18, 2010 12:33 am | by EurekAlert | News | Comments

(The Translational Genomics Research Institute) Predictive Biomarker Sciences Inc. has completed its first drug analysis, enabling Canadian biotech company PharmaGap Inc. to significantly advance a potentially significant anti-cancer medication.

TOPICS:
Advertisement

Women who consume large amounts of tea have increased risk of rheumatoid arthritis

June 18, 2010 12:33 am | by EurekAlert | News | Comments

(European League Against Rheumatism) Women who drink tea have an increased risk of developing rheumatoid arthritis (RA) compared with those who drink none (p=0.04), according to results presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in...

TOPICS:

Partners grieve rheumatoid arthritis diagnosis as much as patients

June 18, 2010 12:33 am | by EurekAlert | News | Comments

(European League Against Rheumatism) Partners of patients newly diagnosed with rheumatoid arthritis are equally emotionally affected by the diagnosis and go through the same grieving process as the patients themselves, according to the results of a study presented today at EULAR...

TOPICS:

Investing in Banks of Stem Cells

June 17, 2010 9:37 pm | by Massachusetts Institute of Technology | News | Comments

Scientists are creating collections of reprogrammed stem cells to use for transplants and drug testing.

Tamiflu: Counterfeit Product Sold on Internet

June 17, 2010 6:31 pm | by U.S. Food & Drug Administration | News | Comments

Potentially harmful product represented as “Generic Tamiflu”- tests revealed product does not contain oseltamivir, but cloxacillin, an antibiotic.

TOPICS:

Moody's upgrades Tenet Healthcare ratings

June 17, 2010 3:45 pm | by The Associated Press | News | Comments

Moody's Investors Service on Thursday upgraded ratings for Tenet Healthcare Corp., citing the company's recently raised guidance for 2010 and overall improvement in operating results.Moody's upgraded the for-profit hospital operator's corporate family rating to "B2" from "B3."On Monday, Tenet...

Advertisement

Taking a stab at a career in medicine

June 17, 2010 3:37 pm | by Arizona State University | News | Comments

Arizona high school students interested in pursuing careers in medicine, nursing, health care or veterinary medicine participated in a summer medical camp at ASU.read more

TOPICS:

Gen-Probe invests $50M in Pacific Biosciences

June 17, 2010 2:45 pm | by The Associated Press | News | Comments

Diagnostic test maker Gen-Probe Inc. said Thursday it invested $50 million in sequencing company Pacific Biosciences, and will work on products that combine technologies developed by each company.The companies said they will work together to explore development of testing systems based on...

Biologics-naive juvenile idiopathic arthritis patients have elevated risk of cancer

June 17, 2010 12:38 pm | by EurekAlert | News | Comments

(European League Against Rheumatism) Biologics-naive juvenile idiopathic arthritis patients may have an increased risk of cancer compared with the general Swedish population, according to research presented today at EULAR 2010, the Annual Congress of the European League Against...

TOPICS:

NT-proBNP is a predictor of CV risk in arthritis patients taking NSAIDs

June 17, 2010 12:38 pm | by EurekAlert | News | Comments

(European League Against Rheumatism) The role of N-terminal pro-B-type natriuretic peptide (NT-proBNP, a protein thought to be a regulator of cardiovascular function) as a robust, non-invasive predictor of cardiovascular risk in patients with arthritis taking cyclooxygenase...

TOPICS:

From head to toe: Deep insights from whole body MRI

June 17, 2010 12:38 pm | by EurekAlert | News | Comments

(Deutsches Aerzteblatt International) Thanks to technical progress, there are now new areas in which whole body magnetic resonance imaging can be used. In the current edition of Deutsches Arzteblatt International, Gerwin Schmidt and his coauthors present a review of possible uses,...

TOPICS:

55th annual meeting of the Health Physics Society

June 17, 2010 12:38 pm | by EurekAlert | News | Comments

(Health Physics Society) "The Future of the Nuclear Industry" will be the Plenary Session topic of the 55th Annual Meeting of the Health Physics Society (HPS) taking place June 28-July 1, 2010, at the Salt Palace Convention Center in Salt Lake City, Utah. The Honorable Gregory D....

TOPICS:

NMT Medical dives on Closure I trial failure

June 17, 2010 12:36 pm | by Mass Device | News | Comments

NMT Medical Inc.'s Closure I trial fails to meet its primary endpoint, sending its stock down nearly 75 percent in late-day trading. A clinical trial of NMT Medical Inc.'s (NSDQ:NMTI) flagship StarFlex device failed to meet its primary endpoint, sending the company's stock...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading